Trends in antineoplastic drug use, cost and prescribing patterns among patients with lung cancer in nine major cities of China, 2016–2020: a retrospective observational study based on inpatient and outpatient hospital data

OBJECTIVES: It is unclear whether the use of antineoplastic drugs for patients with lung cancer in China has changed after the implementation of the national drug price negotiation in 2016 and continual update of clinical guidelines. This study aims to evaluate the trends in antineoplastic drug use,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Jingyuan, Zhou, Lixin, Huang, Lin, Yang, Feng, Liu, Yanguo, Zhang, Chunyan, Zu, Li'an, Fan, Rongrong, Zhang, Xiaohong, Liu, Yi, Feng, Yufei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030656/
https://www.ncbi.nlm.nih.gov/pubmed/36931677
http://dx.doi.org/10.1136/bmjopen-2022-069645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030656/
https://www.ncbi.nlm.nih.gov/pubmed/36931677
http://dx.doi.org/10.1136/bmjopen-2022-069645

Ejemplares similares